The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118306683 11830668 3 F 20160816 20151214 20160829 EXP GB-AUROBINDO-AUR-APL-2015-09407 AUROBINDO 73.00 YR F Y 0.00000 20160829 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118306683 11830668 1 PS Amoxicillin+Clavulanic acid AMOXICILLINCLAVULANIC ACID 1 Oral UNK U U 91568
118306683 11830668 2 SS ALLOPURINOL. ALLOPURINOL 1 Unknown UNK Y U 0
118306683 11830668 3 C CLARITHROMYCIN. CLARITHROMYCIN 1 Unknown 2 DF, UNK U 0 2 DF
118306683 11830668 4 C CLARITHROMYCIN. CLARITHROMYCIN 1 TWO DOSES U 0
118306683 11830668 5 C LOSARTAN. LOSARTAN 1 Unknown U 0
118306683 11830668 6 C SIMVASTATIN. SIMVASTATIN 1 Unknown U 0
118306683 11830668 7 C ASPIRIN. ASPIRIN 1 Unknown U 0
118306683 11830668 8 C DOSULEPIN HYDROCHLORIDE DOTHIEPIN HYDROCHLORIDE 1 Unknown U 0
118306683 11830668 9 C INDAPAMIDE. INDAPAMIDE 1 Unknown U 0
118306683 11830668 10 C LEVOTHYROXINE. LEVOTHYROXINE 1 Unknown U 0
118306683 11830668 11 C METRONIDAZOLE. METRONIDAZOLE 1 Intravenous (not otherwise specified) 500 MG, 3 TIMES A DAY U 0 500 MG TID
118306683 11830668 12 C PHENOXYMETHYLPENICILLIN PENICILLIN V 1 Unknown U 0
118306683 11830668 13 C PHENOXYMETHYLPENICILLIN PENICILLIN V 1 U 0
118306683 11830668 14 C VANCOMYCIN VANCOMYCIN 1 Intravenous (not otherwise specified) 750 MG, TWO TIMES A DAY U 0 750 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118306683 11830668 1 Product used for unknown indication
118306683 11830668 2 Product used for unknown indication
118306683 11830668 3 Product used for unknown indication
118306683 11830668 5 Product used for unknown indication
118306683 11830668 6 Product used for unknown indication
118306683 11830668 7 Product used for unknown indication
118306683 11830668 8 Product used for unknown indication
118306683 11830668 9 Product used for unknown indication
118306683 11830668 10 Product used for unknown indication
118306683 11830668 11 Product used for unknown indication
118306683 11830668 12 Product used for unknown indication
118306683 11830668 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
118306683 11830668 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
118306683 11830668 Acute kidney injury
118306683 11830668 Alanine aminotransferase increased
118306683 11830668 Breast mass
118306683 11830668 Conjunctivitis
118306683 11830668 Diarrhoea
118306683 11830668 Drug reaction with eosinophilia and systemic symptoms
118306683 11830668 Dyspnoea
118306683 11830668 Eosinophil count increased
118306683 11830668 Hepatitis
118306683 11830668 International normalised ratio increased
118306683 11830668 Lip blister
118306683 11830668 Mass excision
118306683 11830668 Oedema peripheral
118306683 11830668 Periorbital oedema
118306683 11830668 Pyrexia
118306683 11830668 Rash erythematous
118306683 11830668 Rash maculo-papular
118306683 11830668 Vomiting
118306683 11830668 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found